Girifl ve (81.7 vs. 87.5, p<0.05). Compared to the group with asymptomatic erosive reflux disease and the control group, the quality of life was also lower in the group that manifested both typical symptoms and extraesophageal symptoms (79.9 vs. 84.5, p<0.05). Compared with the control group, the quality of life was lower in the group with typical symptoms than in the group with extraesophageal symptoms (79.6 vs. 87.5, p<0.05). Conclusions: Regardless of whether the esophagitis was erosive or non-erosive, the quality of life was deteriorated to a greater extent in symptomatic gastroesophageal reflux disease patients than in the control group, and the quality of life was even lower among patients who had typical symptoms than among patients with extraesophageal manifestations.